Slides:



Advertisements
Similar presentations
ANESTHESIA FOR A GERIATRIC PATIENT WITH HEART DISEASE
Advertisements

Acquired Heart Disease
Ryan Hampton January  Risks and benefits of surgery  Timing of surgery  Type of Surgery  Goal is to uncover undiagnosed problems or treat prior.
CLINICAL CASES.
CARDIAC RISK ASSESSMENT FOR NONCARDIAC SURGERY JOHN HAMATY D.O. SOUTH JERSEY HEART GROUP SJHG.ORG.
Jacobi Ambulatory Care Service Medical Consultation: An Overview Lori A. Lemberg, MD Fall 2012.
Leadership. Knowledge. Community. Canadian Cardiovascular Society Antiplatelet Guidelines HEART FAILURE Working Group: Alan D. Bell, MD, CCFP; James D.
Cardiac Issues With Noncardiac Surgery Joseph F. Winget, MD FACC Clinical Assistant Professor University of Vermont Medical School Champlain Valley Cardiovascular.
PREOPERATIVE ASSESSMENT OF THE GERIATRIC PATIENT Cheryl Hinners M.D.
Cardiovascular Pre-Operative Evaluation for Non-Cardiac Surgery Jessica Thom PGY-1.
What is Cardiology Clearance? Sheilah Bernard, MD, FACC Director, Cardiac Amb Services Sheilah Bernard, MD, FACC Director, Cardiac Amb Services 9:30-10:00am.
Copyright ©2007 American College of Cardiology Foundation. Restrictions may apply. Fleisher, L. A. et al. J Am Coll Cardiol 2007;50:e159-e242 Cardiac evaluation.
Focusing on the Surgical Patient with Cardiac Problems By Kate J. Morse, RN, ACNP-BC, CCRN Nursing2009, March ANCC contact hours Online:
Modalities of Cardiac Stress Test
Dean Handimulya UIEU 2005 Congestive Heart Failure Dean Handimulya, M.D.
Epidemiology of Noncardiac Surgery Dr. Mohammed Naser.
Heart disease. Congenital Ischemic Hypertensive Valvular Cardiomyopathy Pericardium Tumors.
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Perioperative Cardiovascular Evaluation for Noncardiac Surgery By :Mahmoud M Othman MD, Prof of Anesthesia & SICU, Mansoura faculty of Medicine.
Preoperative assessment
Perioperative Risk Assessment - Can You Get It Right?
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
Preoperative Cardiac Evaluation Jonathan Hastie January 31, 2006.
PREOPERATIVE EVALUATION
1 Covenants of the Medical Home Neighborhood  How Primary Care Physicians and Specialists can “Choose Wisely”
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Arthur Stillman, M.D., Ph.D., PI Pamela Woodard, M.D., Study Co-chair Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Diagnostic.
Primary Aim To compare outcomes of participants with symptoms of stable angina or angina equivalent evaluated with an anatomic imaging strategy using CCTA.
Cardioprotective Agents in the Total Joint Arthroplasty Patient: Are We Doing Enough? Eric Schwenk MD*, Kishor Gandhi MD MPH*, Javad Parvizi MD^, Eugene.
Perioperative Testing
NYU Medical Grand Rounds Clinical Vignette Jacqueline Lonier, PGY2 November 3rd, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
New guidelines for CABG
Indication and contra-indications for cardiac catheterization
Management of Stable Angina SIGN 96
Lecture Title: Lecture Title: Role of anesthesiologist in pre-operative period Lecturer name: Lecturer name: Prof. Ahmed Abdulmoemn Lecture Date:
Management of Chronic Stable Angina AIMGP Seminar Series Mirek Otremba 2007.
Adi Kartolo University of Ottawa. Initial Presentation 42-year-old African-American male with type 2 diabetes Chief Complaint: increasing body weight.
DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.
- To understand the perioperative period term. - To understand the objectives of preoprative visit. - To identify the risk factors in anesthesia. - To.
Cardio Investigations. Patients presenting with chest pain may be identified as having definite or possible angina from their history alone. Risk Factor.
3/99medslides.com1 Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery ACC/AHA Task Force JACC 1996; 27: Circulation 1996;
ACSM’s Guidelines For Exercise Testing And Prescription : Chapter 3 Pretest Clinical Evaluation David Arnall, Ph.D., P.T., FACSM, ES.
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
Pre-operative Cardiovascular Evaluation: Guidelines and More Eric A. Brody MD, FACC Medical Director, NA Cardiology and Medical Services Associate Professor.
Pre-operative Assessment of the Surgical Patient
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
HARVEY®Simulation Exam VCU Internal Medicine M3 Clerkship IMSPE Exam.
Preoperative Cardiac Evaluation
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
Perioperative Cardiovascular Evaluation SooJoong Kim, MD, PhD. Department of Cardiology, Internal Medicine, Kyunghee University Medical Center.
Cardio-Pulmonary Pre Operative Risk Assessment Andy Shakespeare MD PGY2 Baylor Scott and White IM
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Segment 1 Perioperative Risk Assessment. Need Advice – How Low is Low Dear Consult Sages ; I need your help and guidance to provide better service to.
Indication Contraindication Preparation
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
A Clinical and Echocardiographic Score for Assigning Risk of Major Events After Dobutamine Echocardiograms JACC Vol. 43, No June 2, 2004:2102–7.
Choosing Wisely: Cardiology Jeffrey Ziffra D.O. Mercy Medical Center – North Iowa 10/14/2016.
Ed Vandenberg, MD, CMD Geriatric Section OVAMC & Section of Geriatrics
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
CORONARY ARTERY DISEASE
PREOPERATIVE EVALUATION in the ELDERLY Module 2 CARDIAC ASSESSMENT
Guide on how to manage atrial fibrillation in the office
preoperative evaluation
Intensive Observation Unit Careggi University Hospital, Firenze Italy
Section V: Erectile dysfunction: The patients you see
Train-the-Trainer Cases
Train-the-Trainer Cases
Lee A. Fleisher et al. JACC 2014;64:e77-e137
Train-the-Trainer Cases
Presentation transcript:

Preoperative Evaluation and the 2014 ACC/AHA Guidelines Stephen D. Sisson MD FACP

Objectives To review preoperative evaluation To review issues in perioperative medication adjustment To review preoperative testing To review clinical risk assessment and risk assessment tools To review the role of functional assessment To determine who needs further cardiac testing To determine who might benefit from perioperative beta blockers

Disclosures None

Preoperative Evaluation

What medication adjustments would you recommend for this patient? 64F, PMH: DM, HTN, elevated cholesterol, tobacco; preop for femoral/popliteal bypass. Meds: Metformin 500mg, lisinopril 20mg, HCTZ 25mg daily. Labs, EKG normal. What medication adjustments would you recommend for this patient? Day of surgery, hold metformin and probably HCTZ. New guidelines suggest adding statin. She has only 1 clinical risk factor, so beta blocker not indicated

2014 ACC/AHA Guidelines Continue ACEI/ARB, or restart as soon as clinically feasible postoperatively Continue statins if taking statin Consider initiating statin if undergoing vascular surgery or with clinical indications and undergoing elevated-risk procedures

A 57-year-old during preop for THR mentions increasing angina A 57-year-old during preop for THR mentions increasing angina. Stress test is positive; he then undergoes placement of a drug-eluting stent in his RCA. When should his elective total hip replacement be rescheduled? In 4-6 weeks In 3 months In 6 months In 1 year Could consider elective surgery in 6 months.

Antiplatelet therapy With new DES, can consider elective surgery after 6 months. Try to continue aspirin. In each case, discussion with cardiologist, surgeon and internist should take place. Always try to continue DAPT; if not, at least continue aspirin. Discuss with cardiology and surgery to balance risks.

Additional caveats about meds Look for steroid use >2 wks in prior year Ask specifically about OTC NSAIDs Ask about alcohol and other drugs of abuse

Preoperative cardiac testing Candidate tests: EKG Echocardiogram Cardiac catheterization Stress testing

Preoperative EKG Not useful for low-risk surgical procedures May be considered in those without known CAD* Reasonable for patients with CAD, significant arrhythmia, peripheral arterial disease, CVD, or other significant heart disease* (*except undergoing low risk surgery) No evidence of specific age or procedure when obtaining an EKG alters outcome. Guideline authors did note that the value of a preoperative EKG likely increased as the patient's cardiovascular risk increased and/or the complexity of the surgical procedure increased.

Preoperative Echocardiography Routine preoperative evaluation of LV function is not recommended Reassessment of LV function in clinically stable patients with previously documented LV dysfunction may be considered if there has been no assessment within a year Systolic dysfunction worse than diastolic dysfunction

Preoperative cardiac catheterization Coronary angiography in the asymptomatic patient has no value in preoperative evaluation

Clinical Risk Assessment

Clinical risk assessment Occurs throughout preoperative evaluation Review of systems used to gather information on clinical risk factors not already uncovered in HPI or PMH Combined with functional status and type of surgery to predict perioperative risk

Of the following patients with cardiac conditions, which one may proceed with elective surgery? Patient with aortic stenosis with valve area 0.9cm2 and chest pain Patient with mitral stenosis with dyspnea on exertion Patient with angina that is present at rest Patient with myocardial infarction 3 months ago Correct is D

Cardiovascular risks Ischemic cardiovascular disease Angina Intracoronary stent Myocardial infarction Congestive heart failure Valvular heart disease (AS>MS>AR/MR) Hypertension Arrhythmias

Ischemic cardiovascular disease The presence of the following should postpone surgery: Unstable angina Class III or IV angina Myocardial infarction < 60 days ago

Additional cardiac considerations Cardiac catheterization does not have a role in preoperative risk assessment. Coronary revascularization should not be performed solely to reduce operative risk for another procedure.* *If indicated on its own, revascularize before elective procedure If left main, triple vessel CAD, or 2vv disease incl prox LAD and either EF<50% or + noninvasive testing, revascularization should be performed prior to elective surgery

Congestive heart failure Decompensated congestive heart failure is a contraindication to elective surgery

Valvular heart disease Obtain echo if clinically suspected moderate or severe valvular heart disease if no echo in past year, or clinically changed. Asymptomatic patients may undergo elective noncardiac surgery, even with severe valvular disease, with monitoring Consider mitral valve commisurotomy preoperatively in severe mitral stenosis Patients with indication for valve replacement based on symptoms and/or severity of valve lesion should have the valve taken care of before elective surgery

Hypertension (no specific recommendations)

Arrhythmias Atrial fibrillation: no adjustments (other than anticoagulation) if clinically stable Ventricular arrhythmias do not require special therapy if clinically stable Communicate with Cardiology and surgeon if pacemaker/AICD present Lack of data limits more specific recommendations

Pulmonary Risks Pulmonary risk assessment poorly defined FEV1<1.5 = increased pulmonary complications FEV1<1.0 = likely prolonged intubation Serum albumin <3.5g/dl best predictor of perioperative pulmonary complications (Consider ABG if CO2 retention, COPD, restrictive lung disease)

Other systems Hematologic: h/o bleeding/thrombosis risk, h/o transfusion reaction Endocrine: DM, thyroid, adrenal disease If >2wks. steroids in past year, give stress dose steroids (HC 100mg IV q8H) ID: cancel elective surgery when acute infectious illness present Renal: creatinine > 2.0mg/dl associated with increased risk Neurologic: cerebrovascular disease associated with increased risk

Data gathered thus far Clinical risk factors = Revised Cardiac Risk Index (which also includes high-risk surgery)

Surgery Specific Risk

Surgical Risk Overall perioperative mortality: 0.3% Cardiac etiologies most common cause of death POD#3 most common day for perioperative MI Pulmonary etiologies most common cause of complications Extubation is time of risk for flare of reactive airways

Of the operations listed, which one has the lowest operative risk? Simple mastectomy Prostatectomy Carotid endarterectomy Total knee replacement Correct is A

Low Risk Surgery (<1% risk MI/death) Endoscopic procedures Superficial procedures Cataract surgery Breast surgery Ambulatory surgery

Intermediate and high-risk surgery Carotid endarterectomy Endovascular AAA repair Head and neck surgery Intraperitoneal/intrathoracic surgery Orthopedic surgery Prostate surgery Aortic/major vascular surgery Peripheral vascular surgery

Functional assessment

A 73-year-old woman is to undergo left TKR for DJD. PMH: HTN A 73-year-old woman is to undergo left TKR for DJD. PMH: HTN Meds: HCTZ She has been limited in physical activity because of her knee, but she can walk up 1 flight of stairs without difficulty. How many metabolic equivalents (METs) is she demonstrating? 0 METs 1 MET 4 METs 10 METs Correct answer is C

Functional Assessment ACC/AHA: poor exercise tolerance is the inability to perform 4 METs of activity without symptoms

PMH: HTN, DM, CKD, prior CVA, tobacco use. 64M preop. for AAA repair. PMH: HTN, DM, CKD, prior CVA, tobacco use. Meds: lisinopril, HCTZ, atorvastatin and metformin. ROS: Walks 3 flights of stairs regularly Physical examination: Normal. The surgeon requests an EKG and blood work, which are baseline. Of the options listed, correct management at this point would be: Add metoprolol Obtain a dobutamine echocardiogram Both A and B Proceed with surgery with no changes Correct is A

Perioperative beta blockers Proven to reduce risk of perioperative MI in certain populations Also increases risk of death and stroke in other populations If used, long-acting beta blockers preferable over short-acting

RCT 8300 patients undergoing non-cardiac surgery RCT 8300 patients undergoing non-cardiac surgery. Rx with 100mg metop XL 2-4H preop and in first 6H post op if HR>80 or SBP>100, then metop XL 200mg daily for 30 days. MI/CV death decreased, but CVA/non-cardiac death increased. For every 1000 patients; prevents 15 MI but causes 8 deaths and 5 CVAs

Perioperative beta blockers Continue if already on them Consider starting them if 3 or more Revised Cardiac Risk Index factors Consider if intermediate or high-risk preoperative testing seen Start at least 1 day preoperatively; no proven value in titrating to HR<60

Putting it all together

What we know so far:

Management in other scenarios NSQIP: Multicenter study of >200,000 patients at >250 hospitals Clinical outcomes tracked and compared with clinical risk factors and operative procedure Better predictor of perioperative risk than the RCRI Variables included type or surgery, functional status, abnormal creatinine, ASA class, age National Surgical Quality Improvement Program. Study done in 2011

NSQIP-guided management If surgical risk <1%, proceed with surgery If surgical risk >1% and functional status <4 METS, obtain pharmacologic stress if it would affect management

73F preop for mastectomy for breast cancer. PMH: HTN, DM Meds: Lisinopril, HCTZ, insulin, aspirin She lives on a 1-level apartment, and cooks for herself without any dyspnea. The surgeon has already obtained blood work. Of the options listed, appropriate management at this point would be: Obtain dobutamine echocardiogram Add metoprolol prior to surgery Both A and B Proceed with surgery Correct is D; low risk surgery

44M preoperative for bunion surgery. PMH: Dilated cardiomyopathy from viral myocarditis three years ago. Meds: lisinopril and furosemide. PE: BP 118/68; P66. You note bibasilar rales and mild pedal edema, and the patient admits he's been a little bit more dyspneic recently, and a little less compliant with salt restriction. Appropriate management at this point would be: Double his furosemide and proceed with surgery Add metoprolol then proceed with surgery Both A and B Postpone surgery D. postpone

57M preop for total knee replacement surgery. PMH: heavy smoker, hypertension, diabetes and chronic kidney disease Meds: Lisinopril, HCTZ, insulin, rosuvastatin, aspirin ROS: He is sedentary, lives on a single floor in an elevator building, but is compliant with his medications. Data: A1C 6.5%; creatinine 2.6mg/dl. CXR and EKG done in anticipation of surgery are normal. After instructing the patient about medication adjustments, the next step in preparing this patient for surgery should be: Add metoprolol and proceed with surgery Assess perioperative risk with risk calculator Obtain dobutamine echocardiogram Proceed with surgery Correct is B